Myeloperoxidase inhibitor AZD5904 enhances human sperm function in vitro.

Campbell, M J; Sucquart, I E; Whittaker, A; Sanganee, H J; Barratt, C L R; Martins da Silva, S J

Campbell, M J; Sucquart, I E; Whittaker, A; Sanganee, H J; Barratt, C L R; Martins da Silva, S J.

Afiliación

Campbell MJ; Reproductive Medicine Research Group, School of Medicine, Ninewells Hospital and Medical School, University of Dundee, Dundee, UK.
Sucquart IE; Reproductive Medicine Research Group, School of Medicine, Ninewells Hospital and Medical School, University of Dundee, Dundee, UK.
Whittaker A; Emerging Innovations Unit, Discovery Sciences, R&D, AstraZeneca, Cambridge, UK.
Sanganee HJ; Emerging Innovations Unit, Discovery Sciences, R&D, AstraZeneca, Cambridge, UK.
Barratt CLR; Reproductive Medicine Research Group, School of Medicine, Ninewells Hospital and Medical School, University of Dundee, Dundee, UK.
Martins da Silva SJ; Reproductive Medicine Research Group, School of Medicine, Ninewells Hospital and Medical School, University of Dundee, Dundee, UK.

Hum Reprod ; 36(3): 560-570, 2021 02 18.

Article en En | MEDLINE | ID: mdl-33393586

Asunto(s)

Infertilidad Masculina; Motilidad Espermática; Humanos; Infertilidad Masculina/tratamiento farmacológico; Masculino; Peroxidasa; Escocia; Análisis de Semen; Espermatozoides

Palabras clave

male infertility; myeloperoxidase inhibitor; oxidative stress; sperm; sperm function

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Motilidad Espermática / Infertilidad Masculina Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Humans / Male País/Región como asunto: Europa Idioma: En Revista: Hum Reprod Asunto de la revista: MEDICINA REPRODUTIVA Año: 2021 Tipo del documento: Article País de afiliación: Reino Unido

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google